Skip to content
10-Q

Quarterly Report

VIELA BIO, INC.

0001564590-20-025090

← back to feed
Filed
May 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 13, 2020 51M sh
Capex Q1 2020 · Mar 31, 2020 $149K
Capex Q1 2020 · Mar 31, 2019 $26K
Operating Cash Flow Q1 2020 · Mar 31, 2020 −$10.87M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$18.9M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $163.58M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $200.85M
Stockholders Equity Q1 2020 · Mar 31, 2020 $316.42M
Stockholders Equity Q1 2020 · Dec 31, 2019 $354.51M
Stockholders Equity Q1 2020 · Mar 31, 2019 −$208.73M
Stockholders Equity Q1 2020 · Dec 31, 2018 −$188.39M
Current Liabilities Q1 2020 · Mar 31, 2020 $26.84M
Current Liabilities Q1 2020 · Dec 31, 2019 $29.54M
Current Assets Q1 2020 · Mar 31, 2020 $321.31M
Current Assets Q1 2020 · Dec 31, 2019 $351.04M
Total Assets Q1 2020 · Mar 31, 2020 $343.26M
Total Assets Q1 2020 · Dec 31, 2019 $384.05M
Net Income Q1 2020 · Mar 31, 2020 −$40.78M
Net Income Q1 2020 · Mar 31, 2019 −$20.98M
Operating Income Q1 2020 · Mar 31, 2020 −$42.11M
Operating Income Q1 2020 · Mar 31, 2019 −$21.65M